New hydroxypyrimidinone-containing sulfonamides as carbonic anhydrase inhibitors also acting as MMP inhibitors
作者:M. Alexandra Esteves、Osvaldo Ortet、Anabela Capelo、Claudiu T. Supuran、Sérgio M. Marques、M. Amélia Santos
DOI:10.1016/j.bmcl.2010.04.109
日期:2010.6
(BSA) derivatives bearing a hydroxypyrimidinone (HPM) moiety were synthesized and investigated for their inhibitory activity against several carbonic anhydrase (CA, EC 4.2.1.1) isozymes. They all revealed to be very potent inhibitors (nanomolar order) of the cytosolic CA I and II isozymes, but especially of the transmembrane, tumor-associated CA IX isozyme, a beneficial feature for a potential antitumor
合成了一组带有羟基嘧啶酮(HPM)部分的苯磺酰胺(BSA)衍生物,并研究了它们对几种碳酸酐酶(CA,EC 4.2.1.1)同工酶的抑制活性。它们都显示出是胞质CA I和II同工酶的非常有效的抑制剂(纳摩尔级),但尤其是跨膜的,与肿瘤相关的CA IX同工酶,对这些化合物具有潜在的抗肿瘤作用是有益的。旨在改善CA抑制特异性和增强其基质金属蛋白酶(MMP)抑制活性的进一步结构优化也可能导致具有抗肿瘤剂双重作用机理的新型化合物。